Pediatrics

Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.

Officials with the FDA have approved Jazz Pharmaceuticals' Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness (EDS) in pediatric patients aged 7 to 17 years with narcolepsy.

The FDA has approved dupilumab (Dupixent®, Regeneron and Sanofi) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.

The FDA has approved sarecycline (Seysara, Almirall) for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 9 years and older.

The FDA has expanded the indication of the antiepileptic drug perampanel (FYCOMPA®, Eisai) CIII for monotherapy and adjunctive use in pediatric patients aged 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures.

One lot of Children’s Advil® Suspension, Bubble Gum Flavored Liquid bottles (4 fluid ounces) is being voluntarily recalled by Pfizer Consumer Healthcare

A young patient, aged 11 months, suffered a stroke after being infected with the varicella zoster virus, commonly known as chickenpox.

Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.

The Archives of Disease in Childhood, Education and Practice Edition has published a manuscript that describes a structured approach to chronic cough in children.

Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.

The utility of determining a patient's asthma phenotype is a current research priority, since various phenotypes seem to respond differently to interventions and medication.

Clinicians who work with adolescents who have asthma report numerous adherence barriers.

Children may have to skip school, be admitted to the hospital, and occasionally, children die from asthma attacks. That's a clear call for better intervention on the part of healthcare providers.

For the first time, epilepsy rate estimates have been available for every state, totaling at least 3.4 million individuals living with the disorder.

Education efforts are underway to improve HPV vaccination rates.

With this year's strain of influenza gaining so much attention, due to its severity, it is important to understand and choose the best treatment option for any patient.

Antibiotics may become ineffective in treating E coli if antibiotic resistance continues to increase among children.

The updated 2018 immunization schedules for children and teens has been released by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP).

Chemotherapy is difficult, and in children even more so. Sproutel has teamed up with Aflac to create a companion robot to help children undergo chemotherapy easier.

Officials with the FDA have announced labeling changes to prescription opioid cough and cold medications that contain codeine or hydrocodone.

Danielle McDonald, PharmD, talks about her residency at Rutgers, the State University of New Jersey.

Adjuvanted influenza vaccine 55% more effective after the first dose than non-adjuvanted vaccines.

Age and tumor type most associated with initial insurance denial of cancer treatment, study finds.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.